# A Study to Evaluate the Drug Interaction of ASP015K and Tacrolimus

> **NCT01190670** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 40 (actual)

## Conditions studied

- Healthy
- Pharmacokinetics of ASP015K and Tacrolimus

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** ASP015K

## Key facts

- **NCT ID:** NCT01190670
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01190670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01190670, "A Study to Evaluate the Drug Interaction of ASP015K and Tacrolimus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01190670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*